Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02983903 · ClinicalTrials.gov registry record · NA
Cryobiopsy Versus Forceps Biopsy for Pulmonary Lesions
A NA study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT02983903: Clinical Trial NA study, sponsored by University of Pennsylvania.
NCT02983903 is a NA study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02983903, a NA study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
Purpose: Patients with peripheral lung nodules require evaluation for lung cancer. Our aim is to assess the diagnostic yield of a new technique, transbronchial cryobiopsies, in patients at risk for lung cancer. Target population: Patients referred for bronchoscopy and lung biopsies as a part of their work up for peripheral lung lesions. Procedures: Patients enrolled will have forceps transbronchial biopsies followed by transbronchial cryobiopsies for their lung lesion during bronchoscopy.
Interventions
- PROCEDURE transbronchial biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2016-11 |
| Est. Completion | 2020-03-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02983903
The ClinicalTrials.gov registry entry for NCT02983903 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which transbronchial biopsy is the first listed.
NCT02983903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02983903 about?
NCT02983903 is a clinical study titled "Cryobiopsy Versus Forceps Biopsy for Pulmonary Lesions". Purpose: Patients with peripheral lung nodules require evaluation for lung cancer. Our aim is to assess the diagnostic yield of a new technique, transbronchial cryobiopsies, in patients at risk for lung cancer. Target population: Patients referred for bronchoscopy and lung biopsies as a part of thei...
What is the current status of trial NCT02983903?
This trial is currently terminated. It is a NA study. The enrollment target is 31 participants. The study started on 2016-11. Estimated completion is 2020-03-02.
What interventions are being tested in trial NCT02983903?
The interventions under investigation include: transbronchial biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT02983903?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.